bezafibrate
Bezafibrate improves markers of combined hyperlipidemia, effectively reducing LDL and triglycerides and improving HDL levels. Reference standards of Bezafibrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Bezafibrate (B1115000)
[catalogue_number] => PA EPB1115000
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => bezafibrate-b1115000-paepb1115000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)